Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial
(2017)
Journal Article
Lindsay, J. O., Clark, M., Allez, M., Labopin, M., Rogler, G., Rovira, M., Satsangi, J., Farge, D., Hawkey, C. J., & Ricart, E. (2017). Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial. The Lancet Gastroenterology & Hepatology, 2(6), 399-406. https://doi.org/10.1016/S2468-1253%2817%2930056-0
Background: The randomised controlled ASTIC trial showed no benefit of mobilisation and autologous haematopoietic stem-cell transplantation (HSCT) compared with mobilisation followed by conventional therapy using a stringent primary endpoint (steroid... Read More about Autologous stem-cell transplantation in treatment-refractory Crohn's disease: an analysis of pooled data from the ASTIC trial.